← Research library

The use of prostatilen in treating patients with chronic prostatitis

Observational study · 1991

What was studied
307 men with chronic prostatitis
Main finding
An uncontrolled 307-person chronic-prostatitis series reported symptom disappearance or attenuation in 96.7% after Prostatilen.

Disappearance or attenuation; uncontrolled composite clinical response

Reported findings and study design

An uncontrolled 307-person chronic-prostatitis series reported symptom disappearance or attenuation in 96.7% after Prostatilen.

307 patients aged 18–74; disease duration 4 months–36 years; assessments at treatment completion and 4–6 months later.

Dose, route and schedule

Prostatilen: 5–10 mg intramuscularly once daily for five to ten days.

Protocol source ↗ · Indexed publication abstract

Results · Primary-publication indexed abstract; no full-text table appraisal
MeasureResultComparison, timing and statistics
Reported symptom response96.7%Disappearance or attenuation; uncontrolled composite clinical response
Onset of responseAfter 2–3 injections; greatest reported response after 5–6Descriptive clinical observation
Studied regimen5–10 mg intramuscularly daily for 5–10 days
Participants307

The abstract does not give a placebo response, a validated symptom-score change or separate response rates at each follow-up. Its claim of no side effects is not a systematic incidence estimate.

Source for these results ↗ · Reviewed 2026-11-01

Study limitations and source details

Study limitations

  • The abstract does not establish a randomized concurrent control.
  • Reported tolerability cannot establish long-term safety; findings do not apply to Prostamax.

Source details

Indexed abstract and citation checked via Europe PMC / PubMed; full methods and risk of bias not appraised.

Sources checked

Citation

Uncontrolled human reportEnglish abstract

Tkachuk VN, Gorbachev AG, Khavinson VKh. The use of prostatilen in treating patients with chronic prostatitis Urol Nefrol (Mosk) (6):40-43. PMID 1823682

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards